Immunoenzymatic Assay of Mr 52,000 Cathepsin D in 182 Breast Cancer Cytosols: Low Correlation with Other Prognostic Parameters

Cancer Research

Volumn 48, Issue 2, 1988, Pages 462-466

  Maudelonde, Thierry ^a,b   Khalaf, Siham ^b   Garcia, Marcel ^a   Freiss, Gilles ^a   Duporte, Jacques ^a   Benatia, Marc ^b   Paolucci, Francis ^d   Simony, Joelle ^c   Pujol, Henri ^c   Pau, Bernard ^d   Rochefort, Henri ^a,b,d  

^a INSERM   (France)

^b Maternité ^*  (France)

^c CENTRE VAL D AURELLE   (France)

^d SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

BREAST CANCER; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PROGNOSIS; ADULT; AGED; ARTICLE; BREAST TUMOR; CYTOSOL; ENZYME IMMUNOASSAY; ENZYMOLOGY; LYMPH NODE METASTASIS;

AGED; BREAST NEOPLASMS; CATHEPSIN D; CYTOSOL; FEMALE; HUMAN; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MIDDLE AGE; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SUPPORT, NON-U.S. GOV'T;

EID: 0023818251     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Jensen, E. V., DeSombre, E. R., and Jungblut, P. W. Estrogen receptors in hormone-responsive tissues and tumors. In: R. W. Wissler, T. L. Dao, S. Wood (eds.), Endogenous Factors Influencing Host-Tumor Balance, pp. 15–30. Chicago: University of Chicago Press, 1967.
2. McGuire, W. L. Steroid hormone receptors in breast cancer treatment strategy. Recent Prog. Horm. Res., 36:135-146, 1980.
3. Rochefort, H., Capony, F., Garcia, M., Morisset, M., Touitou, I., and Vignon, F. The 52K protein: an estrogen-regulated marker of cell proliferation in human mammary cells. In: T. Dao, A. Brodie, and C. Ip (eds.), Progress in Clinical and Biological Research Series, Vol. 204, pp. 125–140. New York: Alan R. Liss, Inc., 1986.
4. Westley, B., and Rochefort, H. A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell, 20:352-362,1980.
5. Veith, F. O., Capony, F., Garcia, M., Chantelard, J., Pujol, H., Veith, F., Zajdela, A., and Rochefort, H. Release of estrogen-induced glycoprotein with a molecular weight of 52,000 by breast cancer cells in primary culture. Cancer Res., 43:1861-1868,1983.
6. Garcia, M., Contesso, G., Duplay, H., Cavailles, V., Derocq, D., Delarue, J. C., Krebs, B., Sancho-Garnier, H., Richer, G., Domergue, J., Namer, M., and Rochefort, H. Immunohistochemical distribution of the 52K protein in mammary tumors: a marker associated with cell proliferation rather than with hormone responsiveness. J. Steroid Biochem., 27:439-445, 1987.
7. Garcia, M., Capony, F., Derocq, D., Simon, D., Pau, B., and Rochefort, H. Monoclonal antibodies to the estrogen-regulated Mr 52,000 glycoprotein: characterization and immunodetection in MCF7 cells. Cancer Res., 45:709-716, 1985.
8. Morisset, M., Capony, F., and Rochefort, H. The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease. Biochem. Biophys. Res. Commun., 138:102-109,1986.
9. Capony, F., Morisset, M., Barrett, A. J., Capony, J. P., Broquet, P., Vignon, F., Chambon, M., and Rochefort, H. Phosphorylation, glycosylation and proteolytic activity of the 52K estrogen-induced protein secreted by MCF7 cells. J. Cell Biol., 104:253-262,1987.
10. Vignon, F., Capony, F., Chambon, M., Freiss, G., Garcia, M., and Rochefort
11. H. Autocrine growth stimulation of the MCF7 breast cancer cells by the estrogen-regulated 52K protein. Endocrinology, 118:1537-1545, 1986.
12. Garcia, M., Salazar-Retana, G., Pages, A., Richer, G., Domergue, J., Pages, A. M., Cavalie, G., Martin, J. M., Lamarque, J. L., Pau, B., Pujol, H., and Rochefort, H. Distribution of the Mr 52,000 estrogen-regulated protein in benign breast diseases and other tissues by immunohistochemistry. Cancer Res., 46: 3734-3738,1986.
13. Morisset, M., Capony, F., and Rochefort, H. Processing and estrogen regulation of the 52-kDa protein inside MCF7 breast cancer cell. Endocrinology, 119:2773-2783, 1986.
14. WHO Histological Classification of Breast Tumors, Geneva, Switzerland, Ed. 2, 1981.
15. Bloom, H. J. G., and Richardson, W. W. Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed 15 years. Br. J. Cancer, 11:359-377,1957.
16. Bressot, N., Veith, F., Saussol, J., Pujol, H., Lavie, M., Granier, M., Gary-Bobo, J., and Rochefort, H. Presurgical radiotherapy decreases the concentrations of estrogen and progesterone receptors in human breast cancer a 200-patient study. Breast Cancer Res. Treat, 2:177-183,1982.
17. Nolan, C., Przywara, L. W., Miller, L. S., Suduikis, V. B. S., and Tomita, J. T. A sensitive solid-phase enzyme immunoassay for human estrogen receptor. In: F. C. Ames, G. R. Blumenschein, and E. D. Montague, (eds.), Current Controversies in Breast Cancer, pp. 433–441. Austin, Texas: University of Texas Press, 1984.
18. Goldfarb, R. H. Proteolytic enzymes in tumor invasion and degradation of host extracellular matrix. In: K. V. Honn, W. E. Powers, B. F. Sloane, (eds.), Mechanisms of Cancer Metastasis, pp. 341–375. The Hague: Martinus Nijhoff Publishing, 1986.
19. Abecassis, J., Collard, R., Eber, M., Pusel, J., Flicker, J. P., and Methlin, G. Proteinases and sialyltransferase in human breast tumors. Int. J. Cancer. 33: 821-824,1984.
20. O’Grady, P., Lijnen, H. R., and Duffy, M. J. Multiple forms of plasminogen activator in human breast tumors. Cancer Res., 45:6216-6218,1985.
21. Barrett, A. J. Cathepsin D and other carboxyl proteinases. In: A. J. Barrett (ed.), Proteinases in Mammalian Cells and Tissues, pp. 209–248. Amsterdam: Elsevier/North-Holland Biomedical Press, 1977.